Report of Foreign Issuer (6-k)
April 03 2017 - 6:59AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of April 2017
Commission File Number: 001-37643
KITOV PHARMACEUTICALS HOLDINGS
LTD.
(Translation of registrant's name into English)
One
Azrieli Center, Round Tower, 23
rd
Floor,
132
Menachem Begin Road, Tel Aviv 6701101, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F
☒
Form 40-F
☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Kitov Pharmaceuticals Holdings Ltd.
(the “Company” or the “Registrant”) is announcing that it
issued a press release, “
U.S.
Food and Drug Administration Grants Kitov a Waiver for New Drug Application Filing Fee
”, which is attached hereto as
Exhibit 99.1.
Exhibit 99.1 Press Release
This Form 6-K, including Exhibit
99.1, is incorporated by reference into each of the Registrant’s Registration Statements on Form F-3 filed with the Securities
and Exchange Commission on December 12, 2016 (Registration file numbers 333-207117, 333-211477 and 333-215037) and the
Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on May 20, 2016 (Registration
file number 333-211478).
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
KITOV
PHARMACEUTICALS HOLDINGS LTD.
|
|
|
April
3, 2017
|
By:
|
/s/
Avraham Ben-Tzvi
|
|
|
Avraham
Ben-Tzvi
|
|
|
General
Counsel & Company Secretary
|
3
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Apr 2023 to Apr 2024